Detalhe da pesquisa
1.
Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
Proc Natl Acad Sci U S A
; 119(12): e2112410119, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286196
2.
Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination.
J Infect Dis
; 228(6): 734-741, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210741
3.
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis
; 76(3): 398-407, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210481
4.
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
N Engl J Med
; 383(24): 2320-2332, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877576
5.
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
Lancet
; 397(10287): 1809-1818, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964223
6.
Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
Clin Infect Dis
; 73(11): e4278-e4287, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146720
7.
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
J Infect Dis
; 222(4): 572-582, 2020 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603201
8.
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis
; 220(11): 1802-1815, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402384
9.
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Immun Ageing
; 14: 8, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413427
10.
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
J Infect Dis
; 213(3): 411-22, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259809
11.
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
N Engl J Med
; 378(24): 2346-2348, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897849
12.
Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.
J Infect Dis
; 210(4): 545-57, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652494
13.
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
J Virol Methods
; 327: 114945, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649070
14.
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.
medRxiv
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293205
15.
Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.
J Infect Dis
; 205(5): 733-44, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315336
16.
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 11(2)2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36838333
17.
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.
Microorganisms
; 11(7)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512961
18.
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century.
Hum Vaccin Immunother
; 19(1): 2189885, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37113023
19.
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial.
Open Forum Infect Dis
; 10(1): ofac693, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655191
20.
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine.
Expert Rev Vaccines
; 22(1): 501-517, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246757